Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Chapman
University of Colorado Denver, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Thrombo Therapeutics, Inc.
Other : Dr. Chapman is a key employee/officer who holds an equity interest in Thrombo Therapeutics, Inc.
Dr. Chapman has a significant financial interest due to his roles as key employee/officer, an equity owner, and inventor-intellectual property rights owner with Thrombo Therapeutics, Inc. Thrombo Therapeutics, Inc. holds licenses related to some of the assays used in the following human subjects protocols, which are partially funded by T32 GM008315.
Thrombo Therapeutics, Inc. assays are used for research purposes only. The data from the tests is not accessible for the clinical care providers and does not affect patient care. The results of Thrombo Therapeutics, Inc. assays will not be used for any clinical decision or research subject assignment. Currently, there is no plan to submit Thrombo Therapeutics, Inc. assays data to the FDA
Mechanisms of Post-Injury Organ Failure
PUBLIC HEALTH RELEVANCE Trauma due to mechanical injury consumes more societal resources than cancer and heart disease. The primary objective of our Program is to prepare and inspire surgery trainees to pursue professional careers that encompass basic investigation of the fundamental mechanisms responsible for death and disability following trauma.
Filed on May 06, 2019.
Tell us what you know about Michael Chapman's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Michael Chapman”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Chapman | University of Colorado Denver | Conflict of Interest | Thrombo Therapeutics, Inc. | Value cannot be readily determined |
| Michael Chapman | Georgia Institute of Technology | Conflict of Interest | Fellows Labriola LLP |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.